351
Participants
Start Date
March 24, 2021
Primary Completion Date
December 1, 2024
Study Completion Date
June 30, 2025
RC48-ADC
2.5 mg/kg IV every 2 weeks
Paclitaxel injection
Administered according to label, as one option for Physician's Choice (determined before randomization)
Irinotecan Hydrochloride Injection
Administered according to label, as one option for Physician's Choice (determined before randomization)
Apatinib Mesylate Tablets
Administered according to label, as one option for Physician's Choice (determined before randomization)
RECRUITING
Beijing Cancer Hospital, Beijing
RECRUITING
Affiliated Hospital of Hebei University, Baoding
RECRUITING
China-Japan Friendship Hospital, Beijing
RECRUITING
Luhe Hospital Affiliated to Capital Medical University, Beijing
RECRUITING
Peking University People's Hospital, Beijing
RECRUITING
Jilin Provincial Tumor Hospital, Changchun
RECRUITING
Xiangya Hospital of Central South University, Changsha
RECRUITING
Affiliated Hospital of Chengde Medical College, Chengde
RECRUITING
Three Gorges Hospital Affiliated to Chongqing University, Chongqing
RECRUITING
Fujian Cancer Hospital, Fuzhou
RECRUITING
Guangdong Provincial People's Hospital, Guangzhou
RECRUITING
Southern Hospital of Southern Medical University, Guangzhou
RECRUITING
The First Affiliated Hospital of Sun Yat-sen University, Guangzhou
RECRUITING
The Sixth Affiliated Hospital of Sun Yat-sen University, Guangzhou
RECRUITING
First Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou
RECRUITING
Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou
RECRUITING
Zhejiang Cancer Hospital, Hangzhou
RECRUITING
The Affiliated Tumor Hospital of Harbin Medical University, Harbin
RECRUITING
Anhui Cancer Hospital, Hefei
RECRUITING
Anhui Provincial Hospital, Hefei
RECRUITING
Jinan Central Hospital, Jinan
RECRUITING
Shandong Cancer Hospital, Jinan
RECRUITING
Affiliated Hospital of Jining Medical College, Jining
RECRUITING
The First People's Hospital of Jining City, Jining
RECRUITING
Lanzhou University Second Hospital, Lanzhou
RECRUITING
Linyi Tumor Hospital, Linyi
RECRUITING
Drum Tower Hospital Affiliated to Nanjing University School of Medicine, Nanjing
RECRUITING
Jiangsu Cancer Hospital, Nanjing
RECRUITING
The First Affiliated Hospital of Nanjing Medical University (Jiangsu Provincial People's Hospital), Nanjing
RECRUITING
Qingdao University Hospital, Qingdao
RECRUITING
Ruijin Hospital Affiliated to Shanghai Jiaotong University School of Medicine, Shanghai
RECRUITING
Shanghai Changhai Hospital, Shanghai
RECRUITING
Zhongshan Hospital Affiliated to Fudan University, Shanghai
RECRUITING
Cancer Hospital Affiliated to Shantou University Medical College, Shantou
RECRUITING
Liaoning Cancer Hospital, Shenyang
RECRUITING
Shenzhen People's Hospital, Shenzhen
RECRUITING
The First Affiliated Hospital of Soochow University, Suzhou
RECRUITING
Shanxi Cancer Hospital, Taiyuan
RECRUITING
Tianjin Cancer Hospital, Tianjin
RECRUITING
Weifang People's Hospital, Weifang
RECRUITING
Weihai Municipal Hospital, Weihai
RECRUITING
Huazhong University of Science Tongji Hospital, Tongji Medical College, Wuhan
RECRUITING
The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an
RECRUITING
The First Affiliated Hospital of Xiamen University, Xiamen
RECRUITING
Affiliated Hospital of Qinghai University, Xining
RECRUITING
Qinghai Provincial People's Hospital, Xining
RECRUITING
The First Affiliated Hospital of Xinxiang Medical College, Xinxiang
RECRUITING
Affiliated Hospital of Xuzhou Medical University, Xuzhou
RECRUITING
Xuzhou Central Hospital, Xuzhou
RECRUITING
Subei People's Hospital of Jiangsu Province, Yangzhou
RECRUITING
Yantai Yuhuangding Hospital, Yantai
RECRUITING
Henan Cancer Hospital, Zhengzhou
RemeGen Co., Ltd.
INDUSTRY